Mimedx (MDXG) Operating Expenses (2011 - 2026)

Mimedx has disclosed Operating Expenses across 16 years of filings, most recently posting $57.4 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $57.4 million, down 9.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $166.3 million (up 8.39% YoY), and the FY2025 annual result was $71.6 million, up 15.75% from the prior year.
• Operating Expenses came in at $57.4 million for Q1 2026 at Mimedx, up from $16.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $72.7 million in Q3 2025 to a low of $13.5 million in Q1 2024.
• The 5-year median for Operating Expenses is $55.9 million (2023), against an average of $46.0 million.
• Across the five-year window, Operating Expenses plunged 75.79% in 2024 and jumped 369.11% in 2025, its largest moves.
• Mimedx's Operating Expenses stood at $45.1 million in 2022, then increased by 25.89% to $56.8 million in 2023, then sank by 70.11% to $17.0 million in 2024, then decreased by 2.2% to $16.6 million in 2025, then jumped by 245.59% to $57.4 million in 2026.
• The last three Operating Expenses figures came in at $57.4 million (Q1 2026), $16.6 million (Q4 2025), and $72.7 million (Q3 2025), per Business Quant data.